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Introduction {#sec005}
============

Brain metastases increase morbidity and mortality risk in patients with cancer \[[@pone.0232430.ref001], [@pone.0232430.ref002]\]. According to the Surveillance, Epidemiology, and End Results (SEER) database, the incidence of identified brain metastases among patients with new diagnoses of cancer is 23,598 per year, accounting for 2% of all patients with cancer and 12% of patients with metastases \[[@pone.0232430.ref003]\]. Currently, there are several treatment options available to patients with brain metastases, such as surgical resection and stereotactic radiosurgery (SRS), suitability of which depends on performance status, number, size, and location of brain metastases. However, whole brain radiotherapy (WBRT) remains standard treatment for multiple brain metastases.

Complications associated with WBRT have not been well studied, as patients with multiple brain metastases have a poor survival rate. However, with improvement in treatment, patient survival has also improved, leading to increased interest in treatment-associated risks and side effects \[[@pone.0232430.ref004]\]. Neurocognitive change is an important side effect of WBRT that impacts patients' quality of life \[[@pone.0232430.ref005], [@pone.0232430.ref006]\]. This neurotoxicity is associated with irradiation dose delivered to the hippocampus \[[@pone.0232430.ref007]\]. Intensity-modulated radiation therapy (IMRT) is used to reduce the WBRT dose to the hippocampus \[[@pone.0232430.ref008]\]. In fact, Radiation Therapy Oncology Group (RTOG) 0933 trial has shown that hippocampal sparing WBRT (HS-WBRT) might reduce the risk of neurotoxicity \[[@pone.0232430.ref009]\].

Volumetric-modulated arc therapy (VMAT) is an advanced form of IMRT that delivers radiation dose with a 360-degree rotation of the gantry. Previous studies have shown that VMAT has dosimetric outcomes superior to IMRT in HS-WBRT \[[@pone.0232430.ref010], [@pone.0232430.ref011]\]. Moreover, Sood et al. have reported that VMAT could reduce irradiation dose to the hippocampus and other healthy organs, including the scalp, auditory canals, cochleae, and parotid gland \[[@pone.0232430.ref012]\].

Coplanar arcs are used in VMAT for WBRT with restrictions to the arc range to avoid the lens. This makes satisfactory planning of HS-WBRT with VMAT difficult. In our previous study on parotid gland sparing in WBRT, the head-tilting technique allowed to add anterior and posterior fields to the traditional opposed fields, leaving the lens out of the anterior field \[[@pone.0232430.ref013]\]. This method significantly reduced the dose delivered to the parotid gland and lens. We hypothesized that applying the head-tilting technique to VMAT might allow using full arc range and improve dosimetric parameters. Thus, we compared dosimetric outcomes of VMAT with and without head-tilting technique in HS-WBRT.

Materials and methods {#sec006}
=====================

This study was approved by the Institutional Review Board of the Yeungnam University Medical Center (YUMC 2019-09-070), and the requirement for informed consent was waived due to the retrospective nature of the analysis. We selected patients with multiple brain metastases who had two computed tomography (CT)-simulation between March 2016 and September 2018. One session was in a traditional supine position (sVMAT); the other was with a tilting acrylic supine baseplate (MedTec, USA), used to elevate the patient's head by 40° (htVMAT). A thermoplastic mask was used in all CT-simulation sessions for immobilization ([Fig 1](#pone.0232430.g001){ref-type="fig"}). Patients who had not undergone brain magnetic resonance imaging (MRI) prior to WBRT were excluded. A total of twenty patients were selected; their characteristics are described in [Table 1](#pone.0232430.t001){ref-type="table"}.

![Patient position for computed tomography simulation.\
(A) supine and (B) head-tilt position of volumetric-modulated arc therapy.](pone.0232430.g001){#pone.0232430.g001}

10.1371/journal.pone.0232430.t001

###### Clinical and demographic characteristics of the study sample.

![](pone.0232430.t001){#pone.0232430.t001g}

  Variable                      No. of patients
  ----------------------------- -----------------
  Age (yrs)                     
   Median (range)               60 (47--87)
  Gender                        
   Male                         13
   Female                       7
  Primary of site               
   Non-small cell lung cancer   12
   Small cell lung cancer       7
   Breast cancer                1

We obtained CT images of 2.5-5-mm slice thickness and 2.5-mm axial MRI scans of the head with T2-weighted and gadolinium contrast-enhanced T1-weighted sequence acquisitions. We performed delineation using the fused MRI-CT image set. Clinical target volume (CTV) was defined as the brain parenchyma and the spinal cord up to the lower level of the atlas. Healthy organs, defined as organs at risk (OAR) (including the hippocampus, parotid gland, and lens) were contoured by an experienced radiation oncologist. The hippocampus was contoured according to the RTOG 0933 contouring atlas protocol \[[@pone.0232430.ref014]\]. The hippocampal avoid zone was delineated with a 5-mm margin around the hippocampus. Planning target volume (PTV) was created by expanding CTV by 5 mm in all directions, excluding the hippocampal avoid zone.

The anterior and lateral scout images of both plans are shown in [Fig 2](#pone.0232430.g002){ref-type="fig"}. All VMAT plans used two coplanar arc beams; the first arc beam followed a clockwise rotation, while the second arc beam followed a counter-clockwise rotation. All VMAT plans were individually optimized to meet the constraints described in [Table 2](#pone.0232430.t002){ref-type="table"}. VMAT optimization and dose calculation were performed using anisotropic analytic algorithm (AAA Varian Eclipse TPS, version 15.6.05). The prescribed radiation dose was 30 Gy in 10 fractions and normalized at the isodose line, covering 90% of the PTV.

![Scout image of volumetric-modulated arc therapy.\
(A) anterior and (C) lateral of the supine position, (B) anterior and (D) lateral head-tilt position; PTV (purple), hippocampus (dark green), Rt eye (blue), Lt eye (green), Rt lens (pink), Lt lens (orange).](pone.0232430.g002){#pone.0232430.g002}

10.1371/journal.pone.0232430.t002

###### The optimization constraints.

![](pone.0232430.t002){#pone.0232430.t002g}

  Structure     Constraint      Priority order
  ------------- --------------- ----------------
  Hippocampus   D~max~ ≤16 Gy   1
  PTV           V90% ≥30 Gy     2
  Right lens    D~max~ ≤5 Gy    3
  Left lens     D~max~ ≤5 Gy    3

Abbreviations: PTV, planning target volume.

Conformity index (CI) and homogeneity index (HI) were used to compare the quality of both plans. The CI was defined as follows: $$CI\mspace{360mu} = \mspace{360mu}\frac{{TV}_{RI}}{TV} \times \frac{{TV}_{RI}}{V_{RI}}$$ where TV~RI~ = target volume covered by the reference isodose, TV = target volume, and V~RI~ = volume of the reference isodose. Higher values of CI indicated better plan conformity to the target volume.

The HI was defined as follows: $$HI\mspace{360mu} = \mspace{360mu}\frac{\left. \left( D \right._{2\%} - D_{98\%} \right)}{D_{median}}$$ where D~2%~ and D~98%~ represented delivery dose to 2% and 98% of PTV, respectively, and D~median~ was the median dose to the PTV. Smaller HI indicated better dose homogeneity within the TV. Wilcoxon-signed rank test was used to measure meaningful change in dosimetric outcomes, including CI, HI, and OAR doses between both plans. A p-value \<0.05 was considered statistically significant. All the statistical analyses were performed using SPSS v25.0 (SPSS Inc., Chicago, IL, USA) software package.

Results {#sec007}
=======

All VMAT plans provided good target coverage and hippocampal sparing, as demonstrated in [Fig 3](#pone.0232430.g003){ref-type="fig"}. Dosimetric parameters for both plans are summarized in [Table 3](#pone.0232430.t003){ref-type="table"} and [Fig 4](#pone.0232430.g004){ref-type="fig"}. There were no significant differences in volume of PTV and normal structure between both plans, except for the hippocampus. The volume of the hippocampus in sVMAT was smaller than in htVMAT (4.75±0.79 vs. 4.88±0.77, p\<0.05). The average CI was 0.860±0.006 and 0.864±0.007 for sVMAT and htVMAT, respectively (p \<0.05). The average D~max~, D~2%~, and D~98%~ was 33.89±0.30, 32.60±0.26, and 26.99±0.43, respectively, for sVMAT and 33.94±0.43 Gy (p = 0.47), 32.50±0.32 Gy (p = 0.13), and 27.36±0.48 Gy (p\<0.05), respectively, for htVMAT. The average HI for sVMAT and htVMAT was 0.179±0.019 and 0.167±0.021 (p \<0.05), respectively. There was no significant difference between two plans on D~max~ to the hippocampus. However, the mean dose to the hippocampus of htVMAT (9.91±0.30 Gy) was significantly lower than that of sVMAT (10.36±0.29 Gy, p \<0.05).

![An example of dose distribution in axial, sagittal, and coronal view.\
(A) the supine and (B) head-tilt position of volumetric-modulated arc therapy.](pone.0232430.g003){#pone.0232430.g003}

![Box plots of D~max~ and D~mean~ to (A) the hippocampus, (B) both parotid glands, (C) right lens and (D) left lens.](pone.0232430.g004){#pone.0232430.g004}

10.1371/journal.pone.0232430.t003

###### Comparison of structure volume and dosimetric parameters between volumetric-modulated arc therapy without (sVMAT) and with (htVMAT) head tilt.

![](pone.0232430.t003){#pone.0232430.t003g}

  Structure and index   sVMAT            htVMAT           p-value
  --------------------- ---------------- ---------------- --------------------------------------------
  PTV                                                     
   Volume (cm^3^)       1748.64±201.46   1755.10±187.59   0.628
  Right lens                                              
   Volume (cm^3^)       0.12±0.06        0.14±0.07        0.184
   Mean (Gy)            7.22±1.26        3.29±0.44        0.001[\*](#t003fn002){ref-type="table-fn"}
   Max (Gy)             8.08±1.34        3.81±0.61        0.001[\*](#t003fn002){ref-type="table-fn"}
  Left lens                                               
   Volume (cm^3^)       0.14±0.07        0.15±0.07        0.507
   Mean (Gy)            6.73±1.01        3.33±0.45        0.001[\*](#t003fn002){ref-type="table-fn"}
   Max (Gy)             7.78±1.25        3.92±0.66        0.001[\*](#t003fn002){ref-type="table-fn"}
  Both parotid glands                                     
   Volume (cm^3^)       57.79±23.14      57.96±26.65      0.828
   Mean (Gy)            5.92±1.68        4.77±1.97        0.028[\*](#t003fn002){ref-type="table-fn"}
   Max (Gy)             18.92±3.07       19.28±5.19       0.732
   V15 (%)              3.92±3.49        4.91±6.03        0.836
   V20 (%)              0.15±0.41        0.99±1.66        0.013[\*](#t003fn002){ref-type="table-fn"}
  Hippocampus                                             
   Volume (cm^3^)       4.75±0.79        4.88±0.77        0.003[\*](#t003fn002){ref-type="table-fn"}
   Mean (Gy)            10.36±0.29       9.91±0.30        0.001[\*](#t003fn002){ref-type="table-fn"}
   Max (Gy)             15.21±0.67       15.12±0.74       0.661
  Conformity index      0.860±0.007      0.864±0.008      0.041[\*](#t003fn002){ref-type="table-fn"}
  Homogeneity index     0.179±0.020      0.167±0.021      0.023[\*](#t003fn002){ref-type="table-fn"}

Abbreviations: PTV, planning target volume.

\*Statistically significant

D~max~ and D~mean~ to the right lens in htVMAT was 3.81±0.61 Gy and 3.29±0.44 Gy, respectively, which was significantly lower than that of sVMAT (8.08±1.34 Gy, p \<0.05, and 7.22±1.26 Gy, p \<0.05, respectively). For the left lens, D~max~ and D~mean~ were 3.92±0.66 Gy and 3.33±0.45 Gy, respectively, in htVMAT, also significantly lower than that of sVMAT (7.78±1.25 Gy, p \< 0.05 and 6.73±1.01 Gy, p \< 0.05).

Compared to sVMAT, htVMAT lowered the D~mean~ to both parotid glands from 5.92±1.68 Gy to 4.77±1.97 Gy (p \< 0.05). There were no significant differences between two plans in D~max~ and V15. However, V20 was significantly higher in htVMAT (0.99±1.66%) compared to sVMAT (0.15±0.41%, p \<0.05). [Fig 5](#pone.0232430.g005){ref-type="fig"} shows dose-volume histogram for the two plans in comparison with each organ.

![Mean dose-volume histogram comparison between volumetric-modulated arc therapy without (sVMAT) and with (htVMAT) head tilt.\
(A) hippocampus, (B) both parotid glands, (C) right lens and (D) left lens.](pone.0232430.g005){#pone.0232430.g005}

Discussion {#sec008}
==========

The results of the present study suggest that the head elevation technique (htVMAT) could be useful for planning HS-WBRT with VMAT. Although advanced radiotherapy technologies, including IMRT and VMAT, have made it possible to spare the hippocampus during WBRT, delivering HS-WBRT is challenging, owing to the central location of the hippocampus within the brain. Lee et al. have previously reported that compared to IMRT, VMAT treatment plans produced a more homogenous dose distribution and decreased the maximum point dose to the target \[[@pone.0232430.ref011]\]. In their study, non-coplanar arcs were used for VMAT, owing to limitations associated with the angle of the arc, which prevent direct irradiation to the lens and meeting the dose constraint.

In another study, Shen et al. have divided the target volume into sections centred around the hippocampal avoidance region and used dual arcs to cover the superior and interior parts of the PTV, which overlapped with the HS-WBRT hippocampal avoidance region \[[@pone.0232430.ref014]\]. Meanwhile, Sood et al. have shown that VMAT using two full coplanar arcs is effective at sparing the hippocampus and at significantly reducing irradiation dose to the healthy structures; however, they failed to mention irradiation dose to the lens \[[@pone.0232430.ref012]\]. In a previous study on VMAT, which involved a non-coplanar beam, the D~mean~ to the right lens ranged from 4.55 to 5.90 Gy, with the corresponding left-lens range from 4.68 to 5.59 Gy \[[@pone.0232430.ref011]\]. This was lower than the sVMAT dose in the present study. Based on this finding, it can be inferred that the use of non-coplanar beams in VMAT is effective at reducing dose of lens. However, the use of a non-coplanar beam may require manually rotating the patient's couch during radiotherapy; in addition, full arc therapy is possible only at a certain angle of the non-coplanar beam owing to couch collision in VMAT. Applying the head-tilting technique could reduce irradiation dose to the lens by elevating the patient's head \[[@pone.0232430.ref013]\]. As shown in [Fig 2](#pone.0232430.g002){ref-type="fig"}, elevating the patient's head by 40° can remove the lens from the beam pathway without jeopardizing target coverage. Moreover, the head-tilting technique makes available the full range of the arc, which can then be used without any restrictions in VMAT. Indeed, conformity and homogeneity indices of htVMAT were 0.864 and 0.167, respectively, suggesting a better outcome.

WBRT is associated with learning and memory function decline \[[@pone.0232430.ref005], [@pone.0232430.ref006]\]. Injury to the neural stem cell compartment located in the subgranular zone of the hippocampus is thought to be a major cause of radiation-induced neurocognitive function decline \[[@pone.0232430.ref007]\]. Gondi et al. have reported a dose-response relationship between irradiation dose to the hippocampus and neurocognitive function. They demonstrated that \>7.3 Gy biologically equivalent doses in 2-Gy fractions to 40% of the hippocampus were significantly associated with neurocognitive function impairment \[[@pone.0232430.ref015]\]. In fact, RTOG 0933 has shown that HS-WBRT could preserve memory and quality of life \[[@pone.0232430.ref009]\]. Several studies have shown that the risk of metastases and relapse within the hippocampus after HS-WBRT is low \[[@pone.0232430.ref016], [@pone.0232430.ref017]\].

The RTOG protocol allows the maximum dose of the lens to be \<5--7 Gy \[[@pone.0232430.ref018], [@pone.0232430.ref019]\]. The lens is a radiosensitive organ and an important dose-limiting factor in planning radiotherapy to treat a brain tumour. Radiation dose and cataracts are known to have a linear relationship and are recommended to be kept below 1 Gy to prevent lens toxicity \[[@pone.0232430.ref020]\]. Given the nature of radiotherapy, it is difficult to meet these criteria. However, efforts to reduce dose to the lens without compromising treatment effectiveness are required to continue.

Both VMAT plans proposed in the present study were able to spare the parotid gland; however, the mean dose to the parotid gland was significantly lower in htVMAT. While much of the parotid glands were irradiated \[[@pone.0232430.ref021]\], there was little interest in xerostomia after WBRT. A recent prospective study has shown that clinically significant xerostomia occurred at the end of WBRT, and its occurrence was associated with radiation dose to the parotid glands \[[@pone.0232430.ref022]\]. The study authors have reported that patients with V20 of 47% or higher were at higher risk of more severe and persistent xerostomia. In the present study, irradiation dose to the parotid gland was very small. For both parotid glands, V20 ranged from 0.15% to 0.99%, and D~mean~ ranged from 4.77 Gy to 5.92 Gy in both plans.

Several studies have shown that intensive treatment for metastatic lesions, including surgery and stereotactic radiosurgery (SRS), combined with WBRT might improve local control of oligo-brain metastases \[[@pone.0232430.ref023], [@pone.0232430.ref024]\]. Dobi et al. have reported that dose escalation to brain metastatic lesion can achieve better local control and survival, even among patients with extracranial metastasis \[[@pone.0232430.ref025]\]. To reduce the risk of cognitive decline and improve clinical outcomes, attempts have been made at adding simultaneous integrated boost (SIB) to HS-WBRT. For example, Jiang et al. have demonstrated that HS-WBRT with SIB can be implemented using four modern RT techniques, including step-and-shoot IMRT, dynamic IMRT, VMAT, and helical tomotherapy \[[@pone.0232430.ref026]\]. Specifically, they prescribed 45--50 Gy to metastatic lesion, and 30 Gy to the whole brain, in 10 fractions. D~max~ and D~mean~ to the hippocampus ranged from 13.2 Gy to 16.5 Gy and 9.5 Gy to 10.7 Gy, respectively. Concurrently, D~max~ to the lens ranged from 5.5 Gy to 6.8 Gy in all four modalities. All IMRT plans consisted of non-coplanar fields, and two non-coplanar full arcs were used in the VMAT plan. Considering this evidence, applying a head-tilting baseplate to the HS-WBRT with SIB, which takes advantage of non-coplanar features, might yield similar dosimetric outcomes.

This study has some limitations. First, there were differences in volume of target and normal structures between both plans. These differences could affect the effective mean dose, in particular, when the overall volume was small. For example, in the case of htVMAT, the hippocampus had a significantly larger volume than it had in the case of sVMAT; this discrepancy might have affected the detected difference to the mean dose. Second, a relatively high dose was delivered to the lens in sVMAT, as the treatment plan was optimized to spare the hippocampus and maximize target coverage. Had the lens constrains been a high priority, sVMAT plan would have been difficult to deliver in a way that preserved the hippocampus, while covering the target sufficiently to allow meaningful comparisons with htVMAT.

Conclusion {#sec009}
==========

This is the first study to show that the head-tilting technique (htVMAT) might be useful for planning HS-WBRT with VMAT. This simple method could remove the limitations associated with the arc range, resulting in improved dose distribution and conformity, while sparing healthy organs, including the hippocampus, lens, and parotid gland. Moreover, this method might be useful in planning HS-WBRT with SIB. However, before this method can be widely used in the clinic, further research is needed to verify reproducibility and stability of the head-tilting position required for optimum treatment outcomes.

Supporting information {#sec010}
======================

###### Dose-volume data of volumetric-modulated arc therapy without (sVMAT) and with (htVMAT) head tilt.

(XLSX)

###### 

Click here for additional data file.

###### Conformity index and homogeneity index of volumetric-modulated arc therapy without (sVMAT) and with (htVMAT) head tilt.

(XLSX)

###### 

Click here for additional data file.
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Reviewer \#1: In the manuscript, author compared the dosimetry effects of head tilting setup technique in VMAT based HS-WBRT with traditional two non-coplanar arcs HS-WBRT. Noticeable dose improvements were shown for sparing lens while providing similar target coverages as in traditional VMAT (sVMAT) HS-WBRT plans. It provides clinical meaningful results. However, there are a few questions in the experiment design need to be answered by the author in order to draw the conclusions.

Suggestions

LINE 98 - In Eclipse V15.6, the optimizer has the capability to avoid either entering or exiting certain structure during optimizing. Has this feature been used in these traditional VMAT plans? If not, what is the reason? This feature can often achieve similar results as manually blocking OARs from the beams.

� Response: Thank you for this helpful comment. As the reviewer said, the optimizer in Eclipse V15.6 is able to avoid certain structures during optimizing without requiring to manually block sensitive organs. In the present study, both plans took advantage of this feature, so setting a limit angle to avoid the lens was not necessary.

LINE 118 - Table 2 -- This constrain list is over simplified and can be misleading. Do all VMAT plans use the same fixed constrains, or it's more like a guideline and each plan is fine-tuned individually? Do the sVMAT and htVMAT plans share the same planning guideline?

� Response: Thank you for this comment. The constraints mentioned in the article represent a guideline; both plans were optimized to meet the applicable constraint as well as possible. Each constraint was set based on the parameters provided in the RTOG 0933 protocol. We recognized that the way this issue was presented in the article could have been misleading. We corrected the relevant section as follows:

Page 7. \[Materials and Methods\]

"All VMAT plans were individually optimized to meet the constraints described in Table 2."

LINE 174 -- I guess what author tried to say is that the htVMAT plan mimics using non-coplanar full arcs which is never feasible in reality. However, it's not clear in current manuscript whether or not a plan with non-coplanar partial arc, which is commonly used for brain treatment, can achieve similar result as htVMAT plan. I would suggest author to avoid comparing htVMAT plan with non-coplanar plan in this manuscript. Rather, author should emphasize the improvement of plan quality comparing to the sVMAT technique while keeping the same delivery efficiency (i.e. only two coplanar full arcs) -- of course one can improve the plan quality by complicating the setup techniques with more non-coplanar fields involved, but it's not a fair comparison without considering different delivery complexity.

� Response: Thank you for sharing your insights. Our previous study has found that elevating the patient's head by 40 degrees can remove the lens from the beam pathway without jeopardizing target coverage. Treatment with full arc VMAT, using a non-coplanar beam at this angle is difficult, due to a likely collision with the patient's couch. The original text has been corrected to prevent misinterpretation.

We agree that it might be misleading to directly compare htVMAT with a non-coplanar plan. We have removed this comparison from the present manuscript, as advised

Page 12. \[Discussion\]

"In a previous study on VMAT, which involved a non-coplanar beam, the Dmean to the right lens ranged from 4.55 to 5.90 Gy, with the corresponding left-lens range from 4.68 to 5.59 Gy \[11\]. This was lower than the sVMAT dose in the present study. Based on this finding, it can be inferred that the use of non-coplanar beams in VMAT is effective at reducing dose of lens. However, the use of a non-coplanar beam may require manually rotating the patient's couch during radiotherapy; in addition, there is a limit to the angle of a non-coplanar beam that involves a full arc owing to couch collision in VMAT. Applying the head-tilting technique could reduce irradiation dose to the lens by elevating the patient's head \[13\]. As shown in Fig. 2, elevating the patient's head by 40° can remove the lens from the beam pathway without jeopardizing target coverage."

LINE 181 -- Again, this statement is not clear. Isn't sVMAT a plan with full arc? I wouldn't suggest comparing htVAMT with non-coplanar VMAT plans in this manuscript because it will lead confusion and not relevant to the data from this study.

� Response: Thank you for restating this piece of advice. In the case of sVMAT, even using a full arc, after optimization, the MLC remains closed at an angle where the lens is located to prevent direct radiation to the lens. Therefore, it seems that there is a limit to the arc range that can be used with sVMAT.

We have deleted the comparison between htVMAT and a non-coplanar plan, as advised.

page 12. \[discussion\]

"Moreover, the head-tilting technique makes available the full range of the arc, which can then be used without any restrictions in VMAT."

LINE 222 -- The second point is not clear. Based on the information from table 2, I thought the lens were optimized with higher weighing comparing to PTV, weren't they?

� Response: Thank you for bringing this issue to our attention. The order of priority for plan optimization was from the hippocampus, through the PTV, to the lens. Initially, we worked with a few cases, following a plan that focused on plan optimizing for in the lens, which received higher weighting than did PTV. However, with such parameters, it was difficult to meet the other constraints of sVMAT, including for the hippocampus and PTV. As such, this dose constraint was set to clearly show the effect of head tilting on lens protection, resulting exclusively from a change to the patient\'s position.

Reviewer \#2's comments and responses

Reviewer \#2: The authors present a dosimetric planning study on the used of a head tilting board for hippocampal sparing WBRT. Objectives include adequate coverage of the whole brain while reducing the doses to the hippocampus, lenses, and parotids. They show very minor but significant reductions in dose for the head tilt method and do a good job of trying to relate this dosimetric significance to clinical significance.

The paper is well written and requires little revising.

Specific comments are as follows:

15\. The purpose of the abstract can and should be much more concise. It should be \"To study the dosimetric impact\...\" and not include VMAT background or anything else that will have plenty of coverage in the introduction.

� Response: Thank you for this comment. We have revised accordingly.

Page 2. \[Abstract\]

"Purpose: Coplanar arcs are used with limited arc range to prevent direct beam entrance through the lens, which is challenging for satisfactory planning of hippocampal sparing in whole brain radiotherapy (HS-WBRT) with VMAT. We evaluated the dosimetric impact of applying a head-tilting technique during VMAT, which allows unrestricted use of the arc range."

25\. Small thing, but pick an order that you talk about sVMAT and htVMAT. You introduce them one way then switch them in results. It\'ll make it easier to follow.

� Response: Thank you for your comment. We have revised accordingly.

Page 2. \[Abstract\]

"The mean CI was 0.860±0.007 and 0.864±0.008 (p\<0.05), and mean HI was 0.179±0.020 and 0.167±0.021 (p\<0.05) for sVMAT and htVMAT, respectively."

114\. Consider -\> considered

� Response: Thank you for your comment. We have revised accordingly

Page 9. \[Material and methods\]

"A p-value of less than 0.05 was considered statistically significant."

127\. lowercase p

� Response: Thank you for your comment. We have revised accordingly

Page 10. \[Results\]

"The average Dmax, D2%, and D98% was 33.89±0.30, 32.60±0.26, and 26.99±0.43, respectively, for sVMAT and 33.94±0.43 Gy (p=0.47), 32.50±0.32 Gy (p=0.13), and 27.36±0.48 Gy (p\<0.05), respectively, for htVMAT. The average HI for sVMAT and htVMAT was 0.179±0.019 and 0.167±0.021 (p \<0.05), respectively."

122-131. These look like very minimal differences and some metrics are better for standard and other for tilted. Which are the imports.

� Response: Thank you for raising this issue. As the treatment plans were established with focus on target coverage and hippocampal preservation, the difference in related parameters was minimal. Among them, the key finding was the conformity and dose homogeneity that relatively improved with htVMAT.

147\. Maybe highlight all parameters that are significant for easy reference.

� Response: Thank you for your comment. We have revised accordingly

Page 10. \[Results\]

Table 3. Parameters that showed a statistically significant difference were marked with asterisk.

147\. Hippocampal volume. You note a significance in volume for the hippocampus (higher for ht). Could this be the reason for your improved dosimetric sparing here? You note that it is a small difference, but so are the doses, and both are significant. This should be addressed, probably in the discussion.

� Response: Thank you for your comment. We have revised accordingly

Page14. \[Discussion\]

"First, there were differences in volume of target and normal structures between both plans. These differences could affect the effective mean dose, in particular, when the overall volume was small. For example, in the case of htVMAT, the hippocampus had a significantly larger volume than it had in the case of sVMAT; this discrepancy might have affected the detected difference to the mean dose."

162\. VAMT -\> VMAT

� Response: Thank you for your comment. We have revised accordingly

Page 13. \[Discussion\]

"The results of the present study suggest that the head elevation technique (htVMAT) could be useful for planning HS-WBRT with VMAT"

190\. HA-WBRT -\> HS-WBRT

� Response: Thank you for your comment. We have revised accordingly

Page 14. \[Discussion\]

"In fact, RTOG 0933 has shown that HS-WBRT could preserve memory and quality of life"

221\. This would be where to address the potential issue noted at 147. I\'m not so sure of your assertion here that volume doesn\'t matter here.

� Response: Thank you for your comment. We have revised accordingly

Page14. \[Discussion\]

"First, there were differences in volume of target and normal structures between both plans. These differences could affect the effective mean dose, in particular, when the overall volume was small. For example, in the case of htVMAT, the hippocampus had a significantly larger volume than it had in the case of sVMAT; this discrepancy might have affected the detected difference to the mean dose."
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